European Pharmaceutical Review

SEPTEMBER 7, 2023

The post Alzheimer’s senescent cell combination therapy presents promise appeared first on European Pharmaceutical Review. A larger $3 million, Phase II clinical trial is in process, with the aim to test the effects of clearing senescent cells with the combination therapy, the paper noted.

FDA 98

FDA 98

pharmaphorum

JUNE 7, 2022

This post makes a case for encouraging and supporting presenters in order to get the most out of their expertise. You’ve been invited to deliver a presentation. Presentation success is a ‘team sport’. Before you know it, your presentation is completely off the rails. Does your topic require a presentation?

Communication 98

Communication 98

Outsourcing Pharma

NOVEMBER 29, 2021

The biotech firm has presented data from a study that could offer hope to patients with Parkinsonâs, Gaucher, Alzheimerâs and other neurodegenerative conditions.

115

115

pharmaphorum

APRIL 17, 2024

Discover how AI is transforming medical communications and reshaping the future of healthcare. Learn about the latest trends, technologies, and advancements in this rapidly evolving field.

Communication 64

Communication 64

Drug Store News

FEBRUARY 20, 2024

The graduates of the #MaesaMagicIncubator program include Fuzz Clinic, House of Foster and Squigs Beauty.

103

103

BioPharm

APRIL 1, 2024

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body’s cancer-immune cycle. When the system is in good working order (and protecting us), dead cancer cells release neoantigens.

Immunization 52

Immunization 52

OctariusRx

SEPTEMBER 12, 2022

OctariusRx President and Consultant Pharmacist Victor Alves is presenting “Medication Management: Acing your next Survey” at the 2022 Northeast Conference, presented by the Massachusetts Association of Ambulatory Surgery Centers. The post Victor Alves Presenting at the 2022 Northeast Conference appeared first on OctariusRX.

Controlled Substances 75

Controlled Substances Documentation 75

STAT

MARCH 11, 2024

Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week and framed as revealing serious health risks associated with gender-affirming care, including cancer.

137

137

Viseven

NOVEMBER 6, 2023

The post Viseven Presents New Brand Identity: Reflecting Transformation appeared first on Viseven. The company’s solutions, products, and services are actively used by the TOP 100 Pharma and Life Sciences companies in more than 50 countries around the globe. Follow Viseven on social media: LinkedIn , Twitter, YouTube , and Facebook.

Communication 64

Communication 64

Pharmaceutical Commerce

DECEMBER 18, 2023

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

104

104

Pharmacy Times

JULY 11, 2023

Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.

130

130

STAT

NOVEMBER 30, 2023

Worried about your health? You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s.

Labelling 132

Labelling FDA 132

Pharmaceutical Technology

NOVEMBER 7, 2023

At AAO 2023, results were presented from the Phase IIa trial of Allgenesis’ AG-73305, evaluating its application for the treatment of DME.

59

59

Pharmacy Times

JANUARY 25, 2024

Since 2000, as the number of CDIs has surged, morbidity and mortality also have increased.

137

137

Pharmacy Times

JUNE 21, 2023

Migraines can be a primary diagnosis or a symptom of an underlying medical or psychological condition.

132

132

Pharmacy Times

JANUARY 13, 2023

Pharmacies should ensure appropriate monitoring procedures are in place to prevent contamination and exposure.

132

132

STAT

DECEMBER 20, 2023

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke. He is also trying to fight the long legacy of racism in neuroscience.

118

118

European Pharmaceutical Review

AUGUST 25, 2022

The post Oncolytic viruses: past and present appeared first on European Pharmaceutical Review. human study of TK?positive positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. J Transl med. 2019;17:271.

Immunization 105

Immunization Chemotherapy Packaging 105

Pharmacy Times

DECEMBER 13, 2023

Prefilled diluent and vaccine syringes may be easily mixed up

Vaccines 122

Vaccines 122

STAT

JULY 25, 2023

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal.

98

98

Drug Topics

JANUARY 10, 2023

Careful thought and adjustments are required to avoid exceeding the maximum recommended amount.

187

187

Pharmacy Times

NOVEMBER 18, 2022

A compliance officer role represents an exciting new challenge to ensure safe handling in compliance with United States Pharmacopeia.

111

111

Pharma Times

JANUARY 19, 2024

Company will present vital findings at SRI annual meeting

45

45

Pharmacy Times

SEPTEMBER 26, 2022

Included in the literature review were the known neurologic complications of smallpox, including encephalitis, transverse myelitis, and acute disseminated encephalomyelitis.

149

149

Drug Topics

MARCH 25, 2024

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.

247

247

Outsourcing Pharma

SEPTEMBER 16, 2020

A leader from Iqvia will present an overview of artificial intelligence, machine learning and other technology during this yearâs CPhI Festival of Pharma.

78

78

pharmaphorum

DECEMBER 5, 2022

A vast majority of patients diagnosed with CRPC already present with metastases at the time of diagnosis. The findings will be presented at an upcoming medical meeting and submitted to the FDA for regulatory approval in 2023. Prostate cancer is the most frequently diagnosed cancer in men in 112 countries.

Chemotherapy 59

Chemotherapy Compounding Labelling FDA 59

Pharmacy Times

MAY 18, 2023

As demand increases, pharmacies can diversify by offering brain-function assessments to patients.

122

122

Pharmafile

APRIL 17, 2023

Published date: 17/04/2023 Summary: Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented updated interim clinical efficacy data including subgroup analyses of first-line pancreatic cancer (PDAC) patients treated with the antibody nadunolimab (CAN04) and chemotherapy in the phase I/IIa CANFOUR trial. months; p=0.017).

Chemotherapy 52

Chemotherapy 52

Pharmacy Times

NOVEMBER 24, 2022

Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.

Controlled Substances 145

Controlled Substances 145

Pharmafile

MARCH 1, 2023

Chief Innovation and Strategy Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14th, at 4:05pm EDT. Chief Innovation and Strategy Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14th, at 4:05pm EDT. read more

40

40

Roots Analysis

FEBRUARY 29, 2024

The data are being presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2019. The post ADCs Pipeline Update: Sutro Biopharma Presents Encouraging Data in Patients with Advanced Ovarian Cancer appeared first on Blog. Overall, the ADC therapeutics market is projected to be close to $15 billion by 2030.

40

40

Drug Topics

APRIL 5, 2024

In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.

Patient Care 199

Patient Care 199

Roots Analysis

FEBRUARY 27, 2024

Get a complete list of the presentations, here. The global genome editing market is anticipated to grow at a CAGR of 12.6% during the forecast period 2023-2035.

40

40

Drug Topics

APRIL 10, 2024

Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.

187

187

PharmExec

APRIL 5, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Vaccines 52

Vaccines 52

PharmExec

MARCH 29, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52